Pharma

Your Article Summary

See Latest Articles

Pharma struggles to adapt as patents expire
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/17/08

New threats to drug makers' revenues are rising even as the industry maneuvers to plug huge holes from looming patent expirations. A newly elected U.S. administration under President-elect Barack Obama brings concerns over pricing and further potential scrutiny, at a time when drug companies have already faced increased uncertainty from the regulators of their products.

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Takeda Receives FDA Complete Response Letter for Alogliptin, An Investigational Treatment for Type 2 Diabetes
Takeda Pharmaceuticals North America, 07/02/09

Insulin detemir alert issued by FDA
American Pharmacists Association, 06/15/09

Court Grants Teva Summary Judgment Of Non-Infringement On Eloxatin
Teva Pharmaceutical Industries, 06/19/09

See All of Regulatory Issues